<DOC>
	<DOCNO>NCT02868905</DOCNO>
	<brief_summary>The purpose study compare average methylation epigenetic marker genomic DNA gene ( APP , BACE , LRP , SorL1 ) involve cerebral amyloid homeostasis : - Of obese young adult healthy young adult - Of obese young adult individual affect Alzheimer 's disease ( AD ) obese young adult age ( &lt; 50 year old ) individual affect Alzheimer 's disease ( AD ) never obese . The secondary purpose determine association frequency epigenetic marker element associate metabolic syndrome ( lipidic glycemic analysis , leptinemia , inflammation marker ) clinical one ( visceral fat mass , body mass index ) young adult .</brief_summary>
	<brief_title>Identification Epigenetic Markers Common Obesity Alzheimer 's Disease Women</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Group 1 : 1850 year old woman , age ( 10 year ) socioculturalmatched group 2 Non obese never obese 18.5 &lt; BMI &lt; 25 Folstein MMS &gt; 27 Informed consent Affiliation social security plan Group 2 : 1850 year old woman , age ( 10 year ) socioculturalmatched group 1 Waist size &gt; 88cm 30 &lt; BMI &lt; 45 Insulinresistant patient ( Insulin resistance index , HOMAIR &gt; 3.8 ) Obesity onset childhood ( prepuberty period ) Folstein MMS &gt; 27 Informed consent Affiliation social security plan Group 3 : &gt; 60 year old woman , age ( 10 year ) match group 4 No obesity history ( 18.5 ≤ BMI &lt; 25 adult age ) Sporadic form mild moderate AD demonstration AD physiopathologic process accord new recommendation 2011 National Institute Aging Alzheimer 's Association diagnostic guideline Alzheimer 's disease 15 &lt; Folstein MMS ≤ 26 Informed consent Affiliation social security plan Group 4 : &gt; 60 year old woman , age ( 10 year ) match group 3 Obesity history ( BMI &gt; 30 least one time adult age ) Sporadic form mild moderate AD demonstration AD physiopathologic process accord new recommendation 2011 National Institute Aging Alzheimer 's Association diagnostic guideline Alzheimer 's disease 15 &lt; Folstein MMS ≤ 26 Informed consent Affiliation social security plan Group 1 : &lt; 18 Patient guardianship , curatorship judicial protection Folate supplementation Diabetic glucose intolerant subject Present participation another study neuropsychological evaluation and/or drug administration Pregnant woman Groups 2,3 4 : &lt; 18 Patient guardianship , curatorship judicial protection Folate supplementation Present participation another study neuropsychological evaluation and/or drug administration Group 2 : Pregnant woman Group 4 : Obese overweight patient ( BMI &gt; 25 )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>